Archives of Women's Mental Health

, Volume 8, Issue 4, pp 214–220 | Cite as

Use of antidepressants by pregnant women: Evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making

  • L. Bonari
  • G. Koren
  • T. R. Einarson
  • J. D. Jasper
  • A. Taddio
  • A. Einarson
Original contribution

Summary

Background: The World Health Organization predicts that by 2012, depression will be the number one disease in the world. Thus, many women who become pregnant will require treatment with antidepressants. We are aware that women and their health care providers remain hesitant to prescribe and take these drugs during pregnancy, despite evidence of the relative safety.

Objectives: 1) To determine perception of risk of antidepressant drugs by pregnant women with depression, 2) to determine the efficacy of evidence-based counseling, and 3) to identify determinants that influence women in their decision making regarding the continuation/discontinuation of antidepressants during pregnancy.

Methods: Women who called The Motherisk Program requesting information about the safety of an antidepressant during pregnancy were compared with two other groups: 1) Women who called about antibiotic use (i.e., non-teratogenic drugs used short-term) and 2) women who called about gastric medications (i.e., non-teratogenic drugs used long-term). Their perception of risk was measured before and after evidenced-based information was given and determinants of decision making was also evaluated.

Results: We recruited 100 women taking antidepressants during pregnancy and 100 in each comparison group. Despite receiving evidence-based reassuring information, 15% of antidepressant users, compared to 4% using gastric drugs and 1% using antibiotics, chose to discontinue their medication. The main determinants of decision making were based on: information received prior to calling Motherisk, family and friends advice, the internet, sequence of advice given and if a women was undecided at the time of call.

Conclusions: Women continue to fear taking antidepressants during pregnancy, more so than non psychiatric drugs, however, evidence based counseling can lower this fear, although not totally. Deciding whether to continue to take a medication or not during pregnancy, is a complex decision for women and their healthcare providers to make.

Keywords: Pregnancy; antidepressants. 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bosquet, M, Egeland, B 2001Associations among maternal depressive symptomatology, state of mind and parent and child behaviors: implications for attachment-based interventions.Attach Hum Dev3173199PubMedGoogle Scholar
  2. Chambers, CD, Johnson, KA, Dick, LM, Felix, RJ, Jones, KL 1996Birth outcomes in pregnant women taking fluoxetine.N Engl J Med33510101015CrossRefPubMedGoogle Scholar
  3. Chung, TK, Lau, TK, Yip, AS, Chiu, HF, Lee, DT 2001Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes.Psychosom Med63830834PubMedGoogle Scholar
  4. Einarson, A, Fatoye, B, Sarkar, M, Lavigne, L, Brochu, J, Chambers, C, Mastroiacovo, P, Addis, A, Matsui, D, Schuler, L, Einarson, T, Koren, G 2001aPregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.Am J Psychiatry15817281730CrossRefGoogle Scholar
  5. Einarson, A, Selby, P, Koren, G 2001bAbrupt discontinuation of psychotropic drugs due to fears of teratogenic risk and the impact of counseling.J Psychiatry Neurosci264448Google Scholar
  6. Einarson, A, Bonari, L, Voyer-Lavigne, S, Addis, A, Matsui, D, Johnson, Y, Koren, G 2003A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy.Can J Psychiatry48106110PubMedGoogle Scholar
  7. Kulin, N, Pastuszak, A, Sage, S, Schick-Boschetto, B, Spivey, G, Feldkamp, M,  et al. 1998Pregnancy outcome following maternal use of the new serotonin reuptake inhibitors: a prospective multicentre study.JAMA279609610CrossRefPubMedGoogle Scholar
  8. Kurki, T, Hiilesmaa, V, Raitasalo, R, Mattila, H, Ylikorkala, O 2000Depression and anxiety in early pregnancy and risk for preeclampsia.Obstet Gynecol95487490CrossRefPubMedGoogle Scholar
  9. Marcus, SM, Flynn, HA, Blow, FC, Barry, KL 2003Depressive symptoms among pregnant women screened in obstetric settings.J Women’s Health12373380CrossRefGoogle Scholar
  10. Mathews, TJ, Menacker, F, MacDorman, MF 2003Infant mortality statistics from the 2001 period linked birth/infant death data set.Nat Vital Stat Rep52128Google Scholar
  11. McElhatton, PR, Garbis, H, Elefant, E, Vial, T, Bellemin, B, Mastroiacovo, P,  et al. 1996The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants: A collaborative study of the European Network of Teratology Information Services (ENTIS).Reprod Toxicol10285294CrossRefPubMedGoogle Scholar
  12. Nulman, I, Rovet, J, Stewart, DE, Wolpin, J, Gardener, HA, Theis, J,  et al. 1997Neurodevelopment of children exposed in utero to antidepressant drugs.N Engl J Med336258262CrossRefPubMedGoogle Scholar
  13. Orr, ST, Miller, CA 1995Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings.Epidemiol Rev17165171PubMedGoogle Scholar
  14. Pastuszak, A, Schick-Boschetto, B, Zuber, C, Feldkamp, M, Pinelli, M, Donnenfeld, A, McCormak, M, Leen-Mitchell, M, Woodland, C, Gardner, A, Hom, M, Koren, G 1993Pregnancy outcome following first trimester exposure to fluoxetine.JAMA26922462248CrossRefPubMedGoogle Scholar
  15. Zuckerman, B, Amaro, H, Bauchner, H, Cabral, H 1989Depressive symptoms during pregnancy: relationship to poor health behaviors.Am J Obstet Gynecol16011071111PubMedGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2005

Authors and Affiliations

  • L. Bonari
    • 1
    • 2
  • G. Koren
    • 1
  • T. R. Einarson
    • 2
  • J. D. Jasper
    • 3
  • A. Taddio
    • 4
  • A. Einarson
    • 1
  1. 1.The Motherisk Program, The Hospital for Sick ChildrenTorontoCanada
  2. 2.Faculty of PharmacyThe University of TorontoTorontoCanada
  3. 3.Department of PsychologyUniversity of ToledoToledoU.S.A.
  4. 4.Department of PharmacyThe Hospital for Sick ChildrenTorontoCanada

Personalised recommendations